BRCA deficiency was originally shown to result from coding mutations affecting the BRCA1 or BRCA2 genes, which are the principal determinants of genetic predisposition to breast and ovarian cancers and play central role in Homologous Recombination (HR) Repair, also called BRCA pathway (7). This evidence concerns the gene BRCA1 and ovarian cancer.